Tubiano, Marilou Q.
HRN: 25-60-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/03/2024
08/10/2024
IVT
600mg
Q6
Nonhealing Wound, Both Feet
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes